HKD 11.24
(1.81%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 875.94 Million CNY | -24.63% |
2022 | 1.16 Billion CNY | -11.0% |
2021 | 1.3 Billion CNY | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q2 | 1.07 Billion CNY | 0.0% |
2024 Q1 | 1.07 Billion CNY | 22.69% |
2023 Q4 | 875.94 Million CNY | 4.13% |
2023 FY | 875.94 Million CNY | -24.63% |
2023 Q3 | 841.19 Million CNY | 0.0% |
2023 Q1 | - CNY | -100.0% |
2022 Q4 | 1.16 Billion CNY | 0.0% |
2022 FY | 1.16 Billion CNY | -11.0% |
2021 FY | 1.3 Billion CNY | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Uni-Bio Science Group Limited | 409.99 Million HKD | -113.648% |
CK Life Sciences Int'l., (Holdings) Inc. | 11.24 Billion HKD | 92.212% |